Mechanistically, circ-EGFR functions as a sponge for miR-942-3p, resulting in the upregulation of GAS1 and activation of the Hedgehog (Hh) signaling pathway, thereby promoting the efficacy of cetuximab in CRC. The gene discussed is EGFR; the disease is colorectal carcinoma.